We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+48.4%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$858M
AUM Growth
+$272M
Cap. Flow
+$61M
Cap. Flow %
7.11%
Top 10 Hldgs %
51.45%
Holding
74
New
10
Increased
22
Reduced
15
Closed
14

Top Buys

Rank Stock Value
1
YMAB
Y-mAbs Therapeutics
YMAB
+$23M
2
KRYS icon
Krystal Biotech
KRYS
+$22.3M
3
GKOS icon
Glaukos
GKOS
+$20.9M
4
GBT
Global Blood Therapeutics, Inc.
GBT
+$19.4M
5
GMAB icon
Genmab
GMAB
+$16.3M

Top Sells

Rank Stock Value
1
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$19.5M
2
IOVA icon
Iovance Biotherapeutics
IOVA
+$15.9M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$11M
4
IMMU
Immunomedics Inc
IMMU
+$10.2M
5
ATRC icon
AtriCure
ATRC
+$9.19M

Sector Composition

Rank Sector Weight
1 Healthcare 78.12%
2 Communication Services 3.8%
3 Energy 0.29%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAX icon
51
Baxter International
BAX
$13.5B
$281K 0.03%
3,258
– –
PFE icon
52
Pfizer
PFE
$143B
$277K 0.03%
8,926
– –
AMGN icon
53
Amgen
AMGN
$208B
$258K 0.03%
1,092
– –
BIO icon
54
Bio-Rad Laboratories Class A
BIO
$8.71B
$247K 0.03%
+548
New +$242K
HRC
55
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$233K 0.03%
2,121
– –
A icon
56
Agilent Technologies
A
$39.1B
$225K 0.03%
+2,548
New +$209K
ELV icon
57
Elevance Health
ELV
$81.5B
$209K 0.02%
+795
New +$212K
UNH icon
58
UnitedHealth
UNH
$376B
$204K 0.02%
+692
New +$198K
GRFS
59
Grifois
GRFS
$5.36B
$185K 0.02%
10,166
– –
BLUE
60
DELISTED
bluebird bio
BLUE
– –
-7,106
Closed -$4.23M
CNC icon
61
Centene
CNC
$30.7B
– –
-8,917
Closed -$530K
HRTX icon
62
Heron Therapeutics
HRTX
$93.9M
– –
-691,400
Closed -$8.12M
IOVA icon
63
Iovance Biotherapeutics
IOVA
$1.82B
– –
-530,805
Closed -$15.9M
LABD icon
64
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$71M
– –
-77
Closed -$217K
LMAT icon
65
LeMaitre Vascular
LMAT
$2.32B
– –
-48,129
Closed -$1.2M
TECH icon
66
Bio-Techne
TECH
$11.2B
– –
-101,424
Closed -$4.81M
VCYT icon
67
Veracyte
VCYT
$3.7B
– –
-223,722
Closed -$5.44M
VRTX icon
68
Vertex Pharmaceuticals
VRTX
$121B
– –
-22,828
Closed -$5.43M
TRHC
69
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
– –
-133,858
Closed -$7M
EPZM
70
DELISTED
Epizyme, Inc
EPZM
– –
-195,160
Closed -$3.03M
ITMR
71
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
– –
-81,500
Closed -$960K
ALXN
72
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-122,645
Closed -$11M
AGN
73
DELISTED
Allergan plc
AGN
– –
-2,157
Closed -$382K
1 2
3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, First Light Asset Management held 74 positions worth $858M, up 47% from $586M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

First Light Asset Management deployed $61M of net new capital in Q2 2020, opening 10 new positions and adding to 22 existing holdings. Its largest new stake was Y-mAbs Therapeutics: 607,621 shares worth $26.2M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 77% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was Vapotherm, Inc. Common Stock, an estimated $19.5M trimmed.

  • First Light Asset Management's largest Q2 2020 buy was Y-mAbs Therapeutics: 607,621 shares worth $26.2M.
  • First Light Asset Management added most to Glaukos in Q2 2020, an estimated $20.9M increase.
  • First Light Asset Management's biggest Q2 2020 reduction was Vapotherm, Inc. Common Stock, cutting an estimated $19.5M.
  • First Light Asset Management fully exited Iovance Biotherapeutics in Q2 2020, selling an estimated $15.9M.
  • First Light Asset Management's ten largest holdings make up 51% of its $858M portfolio in Q2 2020.
  • First Light Asset Management opened 10 new positions and closed 14 in Q2 2020.
  • First Light Asset Management's portfolio value rose 47% quarter-over-quarter to $858M.

Based on First Light Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.